Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Jeffrey A Zonder; Vaishali Sanchorawala; Vishal Kukreti; Sascha A Tuchman; Yubin Kang; Divaya Bhutani; Steven Burt; Christiane Houde; Kathy A. Reichel; Silva Pregja; Jeffrey V Matous

doi:10.1182/BLOOD.V130.SUPPL_1.3158.3158

Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Jeffrey A Zonder
, Vaishali Sanchorawala
, Vishal Kukreti
, Sascha A Tuchman
, Yubin Kang
, Divaya Bhutani
, Steven Burt
, Christiane Houde
, Kathy A. Reichel
, Silva Pregja
, Jeffrey V Matous

Karmanos Cancer Institute, Detroit, MI
Boston Medical Center
Princess Margaret Cancer Centre
University of North Carolina at Chapel Hill
Duke University
Wayne State University
Oncology, Karmanos Cancer Institute, Detroit, MI
Colorado Blood Cancer Institute, Denver, CO

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	130
DOIs	https://doi.org/10.1182/BLOOD.V130.SUPPL_1.3158.3158
State	Published - Dec 7 2017
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1182/BLOOD.V130.SUPPL_1.3158.3158License: Unspecified

Cite this

@article{693c34cf72f44ba1bca9b37d7e6ddf86,

title = "Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis",

author = "Zonder, \{Jeffrey A\} and Vaishali Sanchorawala and Vishal Kukreti and Tuchman, \{Sascha A\} and Yubin Kang and Divaya Bhutani and Steven Burt and Christiane Houde and Reichel, \{Kathy A.\} and Silva Pregja and Matous, \{Jeffrey V\}",

note = "Jeffrey A Zonder, Vaishali Sanchorawala, Vishal Kukreti, Sascha A Tuchman, Yubin Kang, Divaya Bhutani, Steven Burt, Christiane Houde, Kathy A. Reichel, Silva Pregja, Jeffrey V Matous; Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis. 2017; 130 (Supplement 1): 3158. doi: https://doi.org/10.1182/blood.V130.Suppl\_1.3158.3158 Download citation file:",

year = "2017",

month = dec,

day = "7",

doi = "10.1182/BLOOD.V130.SUPPL\_1.3158.3158",

language = "American English",

volume = "130",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

AU - Zonder, Jeffrey A

AU - Sanchorawala, Vaishali

AU - Kukreti, Vishal

AU - Tuchman, Sascha A

AU - Kang, Yubin

AU - Bhutani, Divaya

AU - Burt, Steven

AU - Houde, Christiane

AU - Reichel, Kathy A.

AU - Pregja, Silva

AU - Matous, Jeffrey V

N1 - Jeffrey A Zonder, Vaishali Sanchorawala, Vishal Kukreti, Sascha A Tuchman, Yubin Kang, Divaya Bhutani, Steven Burt, Christiane Houde, Kathy A. Reichel, Silva Pregja, Jeffrey V Matous; Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis. 2017; 130 (Supplement 1): 3158. doi: https://doi.org/10.1182/blood.V130.Suppl_1.3158.3158 Download citation file:

PY - 2017/12/7

Y1 - 2017/12/7

UR - https://ashpublications.org/blood/article/130/Supplement%201/3158/114515/Phase-I-Trial-of-Pomalidomide-Bortezomib-and

U2 - 10.1182/BLOOD.V130.SUPPL_1.3158.3158

DO - 10.1182/BLOOD.V130.SUPPL_1.3158.3158

M3 - Article

VL - 130

JO - Blood

JF - Blood

ER -

Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Disciplines

Access to Document

Other files and links

Cite this